Shyam Poludasu, MD

Activated Clotting Time (ACT)-Guided Intravenous Dalteparin Dosing during Percutaneous Coronary Intervention

08/01/2008

The superiority of low-molecular weight heparin (LMWH) over unfractionated heparin (UFH) in the management of acute coronary syndrome (ACS) patients was demonstrated in the Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary...

The superiority of low-molecular...

08/01/2008

Journal of Invasive Cardiology

Original Contribution

High-Dose Tirofiban Administered as Bolus-Only during
Percutaneous Coronary Intervention

08/01/2008

Nagarathna Manjappa , MD;

Jonathan D. Marmur , MD, FACC;

Erdal Cavusoglu , MD;

Shyam Poludasu , MD;

Ajay Agarwal , MD;

Inhibition of platelet glycoprotein IIb/IIIa receptors during percutaneous coronary intervention (PCI) using tirofiban, eptifibatide and abciximab has been associated with improved outcomes.1 The only head-to-head comparison to these agents...

Inhibition of platelet...

08/01/2008

Journal of Invasive Cardiology

Original Contribution

Impact of Gender on In-Hospital Percutaneous Coronary Interventional Outcomes in African-Americans

08/01/2008

Jonathan D. Marmur , MD, FACC;

Erdal Cavusoglu , MD;

Luther T. Clark , MD;

Shyam Poludasu , MD;

Multiple studies have demonstrated that women are at increased risk for in-hospital mortality, stroke, vascular complications, repeat revascularization, and same-admission coronary artery bypass graft surgery (CABG) after percutaneous...

Multiple studies have...

08/01/2008

Journal of Invasive Cardiology

Original Contribution

Bolus-Only Platelet Glycoprotein IIb/IIIa Inhibition During Percutaneous Coronary Intervention

08/01/2008

Reuven Lapin , PA-C, PA;

Shyam Poludasu , MD;

Jonathan D. Marmur , MD, FACC;

Erdal Cavusoglu , MD;

Pompeiu Vladutiu , MD;

Ajay Agarwal , MD;

Alan Feit , MD;

Several large randomized clinical trials and meta-analyses have shown that inhibition of platelet aggregation with platelet glycoprotein IIb/IIIa inhibitors (GPI) improves outcomes in patients presenting with acute coronary syndromes and in...

Several large randomized...

08/01/2008

Journal of Invasive Cardiology

Original Contribution

Impact of Body Mass Index on Long-Term All-Cause Mortality after Percutaneous Coronary Intervention in African-Americans

01/06/2009

Shyam Poludasu , MD;

Waqas Khan , MD;

Jonathan D. Marmur , MD, FACC;

Erdal Cavusoglu , MD;

ABSTRACT: Background. Studies on body mass index (BMI) and post-percutaneous coronary intervention (PCI) outcomes have suggested an “obesity paradox” (lower post-PCI mortality rates in obese patients compared to patients of normal weight)....

ABSTRACT: Background. Studies on...

01/06/2009

Journal of Invasive Cardiology

Review

Avoiding Intelligence Failures in the Cardiac Catheterization Laboratory (Full title below)

12/04/2009

Shyam Poludasu , MD;

Renee P. Bullock-Palmer , MD;

Jonathan D. Marmur , MD, FACC;

Erdal Cavusoglu , MD;

Avoiding Intelligence Failures in the Cardiac Catheterization Laboratory: Strategies for the Safe and Rational Use of Dalteparin or Enoxaparin during Percutaneous Coronary Intervention ABSTRACT: Low-molecular-weight heparin (LMWH) has been a...

Avoiding Intelligence Failures...

12/04/2009

Journal of Invasive Cardiology